// App-Quantinova.ai

TP1290 : Effectiveness and safety of a modified Dermatophagoides Pteronyssinus allergoid, associated with microcrystalline tyrosine, in adult patients with allergic rhinitis, with or without asthma

Researchers

Presenter

  • Roger A

Principal Investigators

  • Moreno V

  • Malet A

  • Gutirrez D

  • De La Roca F

  • Justicia JL

Medical Centers

  • Hospital Germans Trias i Pujol, Barcelona, Spain

  • Centro de Especialidades Médicas Integradas, Huelva, Spain

  • Al·lergo Centre, Barcelona, Spain

  • Clínica Virgen del Rosario, Algeciras, Spain

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Allergy Therapeutics Ltd, Worthing, United Kingdom

Locations

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Allergic rhinitis

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved